ScoreWhy is Veracyte, Inc. ?
1
Poor Management Efficiency with a low ROE of 0.76%
- The company has been able to generate a Return on Equity (avg) of 0.76% signifying low profitability per unit of shareholders funds
2
The company has declared Positive results for the last 11 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 93.44 MM
- ROCE(HY) Highest at 2.24%
- DEBTORS TURNOVER RATIO(HY) Highest at 9.48 times
3
With ROE of 3.21%, it has a fair valuation with a 1.80 Price to Book Value
- Over the past year, while the stock has generated a return of 20.15%, its profits have risen by 495% ; the PEG ratio of the company is 0.1
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating performance in long term as well as near term
- Along with generating 20.15% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Veracyte, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Veracyte, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Veracyte, Inc.
8.59%
2.36
57.86%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
33.61%
EBIT Growth (5y)
25.87%
EBIT to Interest (avg)
-14.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.35
Tax Ratio
5.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0.63%
ROE (avg)
0.76%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
1.80
EV to EBIT
64.70
EV to EBITDA
35.87
EV to Capital Employed
2.04
EV to Sales
4.04
PEG Ratio
0.12
Dividend Yield
NA
ROCE (Latest)
3.16%
ROE (Latest)
3.21%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 93.44 MM
ROCE(HY)
Highest at 2.24%
DEBTORS TURNOVER RATIO(HY)
Highest at 9.48 times
RAW MATERIAL COST(Y)
Fallen by -1.82% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -22.12 %
NET SALES(Q)
Highest at USD 130.16 MM
OPERATING PROFIT(Q)
Highest at USD 19.8 MM
PRE-TAX PROFIT(Q)
Highest at USD 19.83 MM
-14What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 7.26 times
NET PROFIT(Q)
Lowest at USD -15.55 MM
EPS(Q)
Lowest at USD -0.01
Here's what is working for Veracyte, Inc.
Operating Cash Flow
Highest at USD 93.44 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD 19.83 MM has Grown at 165.78%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Debtors Turnover Ratio
Highest at 9.48 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Highest at USD 130.16 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 19.8 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 19.83 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Debt-Equity Ratio
Lowest at -22.12 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -1.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Veracyte, Inc.
Net Profit
At USD -15.55 MM has Fallen at -367.5%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Net Profit
Lowest at USD -15.55 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.01
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Inventory Turnover Ratio
Lowest at 7.26 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
